>
Switch to:

Creative Medical Technology Holdings Beneish M-Score

: -14.80 (As of Today)
View and export this data going back to 2009. Start your Free Trial

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -14.8 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Creative Medical Technology Holdings's Beneish M-Score or its related term are showing as below:

OTCPK:CELZ' s Beneish M-Score Range Over the Past 10 Years
Min: -25.55   Med: -16.63   Max: 2.84
Current: -14.8

-25.55
2.84

During the past 13 years, the highest Beneish M-Score of Creative Medical Technology Holdings was 2.84. The lowest was -25.55. And the median was -16.63.


Creative Medical Technology Holdings Beneish M-Score Historical Data

The historical data trend for Creative Medical Technology Holdings's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Creative Medical Technology Holdings Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Beneish M-Score
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 2.84 -18.51 -16.63

Creative Medical Technology Holdings Quarterly Data
Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21
Beneish M-Score Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -20.88 -21.99 -16.63 -12.37 -14.80

Competitive Comparison

For the Biotechnology subindustry, Creative Medical Technology Holdings's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Creative Medical Technology Holdings Beneish M-Score Distribution

For the Biotechnology industry and Healthcare sector, Creative Medical Technology Holdings's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Creative Medical Technology Holdings's Beneish M-Score falls into.



Creative Medical Technology Holdings Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Creative Medical Technology Holdings for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0+0.528 * 0.9823+0.404 * 0.8605+0.892 * 0.8468+0.115 * 1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.3695+4.679 * -2.4358-0.327 * 0.1884
=-14.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun21) TTM:Last Year (Jun20) TTM:
Accounts Receivable was $0.00 Mil.
Revenue was 0.01 + 0 + 0.018 + 0.077 = $0.11 Mil.
Gross Profit was 0.006 + 0 + 0.01 + 0.059 = $0.08 Mil.
Total Current Assets was $0.16 Mil.
Total Assets was $0.73 Mil.
Property, Plant and Equipment(Net PPE) was $0.00 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.08 Mil.
Selling, General, & Admin. Expense(SGA) was $1.38 Mil.
Total Current Liabilities was $1.45 Mil.
Long-Term Debt & Capital Lease Obligation was $0.00 Mil.
Net Income was -2.905 + 27.836 + -38.62 + 0.395 = $-13.29 Mil.
Non Operating Income was -2.155 + 28.476 + -37.978 + 0.927 = $-10.73 Mil.
Cash Flow from Operations was -0.222 + -0.442 + 0.057 + -0.174 = $-0.78 Mil.
Accounts Receivable was $0.00 Mil.
Revenue was 0.028 + 0.042 + -0.004 + 0.058 = $0.12 Mil.
Gross Profit was 0.017 + 0.028 + -0.008 + 0.05 = $0.09 Mil.
Total Current Assets was $0.04 Mil.
Total Assets was $0.44 Mil.
Property, Plant and Equipment(Net PPE) was $0.00 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.05 Mil.
Selling, General, & Admin. Expense(SGA) was $1.19 Mil.
Total Current Liabilities was $4.65 Mil.
Long-Term Debt & Capital Lease Obligation was $0.00 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Accounts Receivable in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(0 / 0.105) / (0.001 / 0.124)
=0 / 0.00806452
=0

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(0.087 / 0.124) / (0.075 / 0.105)
=0.7016129 / 0.71428571
=0.9823

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (0.159 + 0) / 0.732) / (1 - (0.04 + 0) / 0.443)
=0.78278689 / 0.90970655
=0.8605

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=0.105 / 0.124
=0.8468

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0.049 / (0.049 + 0)) / (0.08 / (0.08 + 0))
=1 / 1
=1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(1.38 / 0.105) / (1.19 / 0.124)
=13.14285714 / 9.59677419
=1.3695

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 1.447) / 0.732) / ((0 + 4.648) / 0.443)
=1.97677596 / 10.49209932
=0.1884

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-13.294 - -10.73 - -0.781) / 0.732
=-2.4358

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Creative Medical Technology Holdings has a M-score of -14.80 suggests that the company is unlikely to be a manipulator.


Creative Medical Technology Holdings Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Creative Medical Technology Holdings's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Creative Medical Technology Holdings Business Description

Creative Medical Technology Holdings logo
Industry
Healthcare » Biotechnology NAICS : 325412 SIC : 2834
Traded in Other Exchanges
N/A
Address
211 E Osborn Road, Phoenix, AZ, USA, 85012
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid-derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
Executives
Ichim Thomas director 2027 E. CEDAR ST. TEMPE AZ 85281

Creative Medical Technology Holdings Headlines

From GuruFocus

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)